The injectable opioid reversal medication, naloxone, is in significant short supply. The main producer, Pfizer Pharmaceuticals, stopped production in April 2021 due to manufacturing issues. The Opioid Safety and Naloxone Network (OSNN) buyers’ club, a collective of harm reduction programs across the country, is the biggest buyer of the medication. They estimate that there is a 250,000-dose backorder and Pfizer reports they will not begin production until February 2022. If you or a loved one is in need of naloxone, please contact your local ROPS coordinator or join us for one of our Stayin’ Alive Fridays.